For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Bühlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold >1500 BTU than at >1000 BTU. The best value of specificity was obtained at threshold >7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.

Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy / G. Liberatore, C. Giannotta, B.P. Sajeev, E. Morenghi, F. Terenghi, F. Gallia, P.E. Doneddu, F. Manganelli, D. Cocito, M. Filosto, G. Antonini, G. Cosentino, G.A. Marfia, A.M. Clerici, G. Lauria, T. Rosso, G. Cavaletti, E. Nobile-Orazio. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 345:(2020 Aug 15). [10.1016/j.jneuroim.2020.577288]

Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy

C. Giannotta
Secondo
;
F. Gallia;G. Lauria;E. Nobile-Orazio
Ultimo
Writing – Review & Editing
2020

Abstract

For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Bühlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold >1500 BTU than at >1000 BTU. The best value of specificity was obtained at threshold >7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.
Anti-MAG polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; ELISA; Sensitivity; Specificity
Settore MED/26 - Neurologia
15-ago-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
MAG manuscript edo.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 233.75 kB
Formato Adobe PDF
233.75 kB Adobe PDF Visualizza/Apri
1-s2.0-S0165572820301922-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 506.7 kB
Formato Adobe PDF
506.7 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/779424
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 17
social impact